Sihuan Pharmaceutical to Approve Annual Results and Dividend

Sihuan Pharmaceutical Holdings Group ( (HK:0460) ) just unveiled an announcement.

Sihuan Pharmaceutical Holdings Group Ltd. has announced a board meeting scheduled for March 28, 2025, to approve the annual results for the year ended December 31, 2024, and discuss the potential payment of a final dividend. This meeting is significant as it will determine the company’s financial performance and shareholder returns, impacting its market positioning and stakeholder interests.

More about Sihuan Pharmaceutical Holdings Group

Sihuan Pharmaceutical Holdings Group Ltd. is a company incorporated in Bermuda, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and distribution of pharmaceutical products, with a market presence primarily in Hong Kong.

YTD Price Performance: -2.00%

Technical Sentiment Consensus Rating: Strong Buy

Current Market Cap: $720.4M

For an in-depth examination of 0460 stock, go to TipRanks’ Stock Analysis page.